Laquinimod dampens IL-1β signaling and Th17-polarizing capacity of monocytes in patients with MS - Engel, Sinah; Jolivel, Valérie; Kraus, Stefan H.-P.; Zayoud, Morad; Rosenfeld, Karolina; Tumani, Hayrettin; Furlan, Roberto; Kurschus, Florian; Waisman, Ari; Luessi, Felix (Neurology: Neuroimmunology & Neuroinflammation ; official journal of the American Academy of Neurology, 2021)
First published November 17, 2020